Skip to main content
. Author manuscript; available in PMC: 2017 Nov 28.
Published in final edited form as: Biochem Pharmacol. 2015 Sep 30;98(4):671–680. doi: 10.1016/j.bcp.2015.09.020

Fig. 4. miRNA hsa-miR-29a-3p inhibited endogenous ALDH5A1 and SLC22A7 expression in HepaRG cells.

Fig. 4

Differentiated HepaRG cells were transiently transfected using 50 nmol/L miRNA negative control or hsa-miR-29a-3p mimic. Each assay was carried out in triplicate. *P <0.05; **P <0.001; NC, miRNA negative control. Down-regulated mRNA levels (A) and protein levels (B) of ALDH5A1 were observed by hsa-miR-29a-3p mimic transfection. Down-regulated mRNA levels (C) and protein levels (D) of SLC22A7 were observed by hsa-miR-29a-3p mimic transfection. Data are shown as relative ALDH5A1 or SLC22A7 levels normalized by GAPDH levels.